NCT06634355View on ClinicalTrials.gov

Placental Transfer of Sugammadex in the Human Placental Perfusion Model

NAEnrolling by invitationINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

March 17, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2026

Conditions
Pregnancy
Interventions
DRUG

Sugammadex

In an ex-vivo placenta perfusion study, placental transfer of sugammadex is measured.

Trial Locations (1)

3000

UZ Leuven, Leuven

All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER